Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Zyclara (Imiquimod).
Exposure to sunlight: You should avoid or minimize any exposure to sunlight (including sunlamps) and use protective clothing (such as long sleeves and a hat) during treatment with Zyclara (Imiquimod) cream due to an increased risk of Sunburn. If you get a sunburn, stop using the medication until you are fully recovered.
Immunosuppressed individuals: The safety and effectiveness of Zyclara (Imiquimod) cream has not been determined for people with medical conditions affecting the immune system (e.g., HIV/AIDS, Lupus, psoriasis) or people taking medications that reduce the effectiveness of the immune system. If you have any condition affecting the immune system, discuss with your doctor how Zyclara (Imiquimod) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Zyclara (Imiquimod), and whether any special monitoring is needed.
New actinic keratosis (AK) lesions: During treatment with Zyclara (Imiquimod) cream, new AK lesions may develop, but may clear with treatment. Even though initial AK lesions disappear with treatment, new lesions may develop in the future and will require further treatment. Keep in mind that AK is considered to be a chronic skin condition, and Zyclara (Imiquimod) cream is not a cure.
Skin colour changes: Some people using Zyclara (Imiquimod) cream notice that the area where the cream was applied has become lighter or darker. Sometimes, the change in skin colour is permanent.
Skin reactions: If you experience a severe skin reaction to this cream, wash the area with mild soap and water. Once the reaction has cleared, start using the cream again, unless your doctor has told you to stop using it.
Pregnancy: Zyclara (Imiquimod) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Zyclara (Imiquimod), contact your doctor immediately.
Breast-feeding: It is not known if Zyclara (Imiquimod) passes into breast milk. If you are a breast-feeding mother and are taking Zyclara (Imiquimod), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Zyclara (Imiquimod) have not been established for children under 18 years of age.